Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TONI study: Tobramycin nebulisation with I-neb in children with cystic fibrosis
2012-002503-17Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tobramycin in cystic fibrosis (CF) (2 arms), sponsored by Erasmus MC. Primary endpoint: Systemic bioavailability of inhaled tobramycin. Started Aug 2012; status: active.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2012-002503-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002503-17.